How much revenue did XiAn International Medical Investment Co generate this year?
XiAn International Medical Investment Co has achieved a revenue of 5.6 B CNY this year.
XiAn International Medical Investment Co Revenue 2024
XiAn International Medical Investment Co Revenue
5.6 B CNY
Ticker
000516.SZ
ISIN
CNE000000016
In 2024, XiAn International Medical Investment Co's sales reached 5.6 B CNY, a 21.22% difference from the 4.62 B CNY sales recorded in the previous year.
The XiAn International Medical Investment Co Revenue history
| YEAR | REVENUE (undefined CNY) | GROSS MARGIN (%) |
|---|---|---|
| 2026e | 7.96 | 5,52 |
| 2025e | 6.75 | 6,51 |
| 2024e | 5.6 | 7,86 |
| 2023 | 4.62 | 9,52 |
| 2022 | 2.71 | -6,75 |
| 2021 | 2.92 | 1,47 |
| 2020 | 1.61 | -9,21 |
| 2019 | 0.99 | 14,31 |
| 2018 | 2.04 | 21,60 |
| 2017 | 4.06 | 19,26 |
| 2016 | 3.93 | 19,57 |
| 2015 | 3.9 | 19,41 |
| 2014 | 3.88 | 19,79 |
| 2013 | 3.57 | 19,07 |
| 2012 | 3.4 | 18,30 |
| 2011 | 3.38 | 16,22 |
| 2010 | 2.53 | 17,64 |
| 2009 | 2.32 | 14,49 |
| 2008 | 2.04 | 15,14 |
| 2007 | 1.77 | 15,89 |
| 2006 | 1.72 | 15,16 |
| 2005 | 1.63 | 11,34 |
| 2004 | 1.51 | 11,54 |
XiAn International Medical Investment Co Revenue, EBIT, Net Income CNE000000016 ·
3 years
5 years
10 years
25 Years
Max
Revenue
EBIT
Net Income
Details
Revenue, EBIT and Profit
ⓘUnderstanding Revenue, EBIT, and Income
Gain insights into XiAn International Medical Investment Co, a comprehensive overview of its financial performance can be obtained by analyzing the Revenue, EBIT, and Income chart. Revenue represents the total income generated by XiAn International Medical Investment Co from its primary operations, showcasing the company’s ability to attract and retain clients. EBIT, or Earnings Before Interest and Taxes, indicates the company’s operational profitability, free from the influence of tax and interest expenses. The Income section reflects XiAn International Medical Investment Co’s net earnings, an ultimate measure of its financial health and profitability.
Yearly Analysis and Comparisons
Observe the yearly bars to understand the annual performance and growth of XiAn International Medical Investment Co. Compare the Revenue, EBIT, and Income to evaluate the company’s efficiency and profitability. A higher EBIT compared to the previous year suggests an improvement in operational efficiency. Likewise, an increase in Income indicates enhanced overall profitability. Analyzing the year-to-year comparison assists investors in understanding the company’s growth trajectory and operational efficiency.
Utilizing Expectations for Investment
The expected values for the forthcoming years offer investors a glimpse into XiAn International Medical Investment Co’s anticipated financial performance. Analyzing these projections alongside historical data aids in making informed investment decisions. Investors can gauge the potential risks and returns, aligning their investment strategies accordingly to optimize profitability and mitigate risks.
Investment Insights
Leveraging the comparison between Revenue and EBIT helps in assessing XiAn International Medical Investment Co’s operational efficiency, while the Revenue and Income comparison reveals the net profitability after accounting for all expenses. Investors can derive valuable insights by meticulously analyzing these financial parameters, laying the foundation for strategic investment decisions aimed at capitalizing on XiAn International Medical Investment Co’s growth potential.
XiAn International Medical Investment Co Revenue, EBIT and net profit per share
| Date | XiAn International Medical Investment Co Revenue | XiAn International Medical Investment Co EBIT | XiAn International Medical Investment Co Net Income |
|---|---|---|---|
| 2026e | 7.96 B undefined | 816.08 M undefined | 438.33 M undefined |
| 2025e | 6.75 B undefined | 376.73 M undefined | 308.2 M undefined |
| 2024e | 5.6 B undefined | 178.77 M undefined | 91.32 M undefined |
| 2023 | 4.62 B undefined | -329.54 M undefined | -368.36 M undefined |
| 2022 | 2.71 B undefined | -893.77 M undefined | -1.18 B undefined |
| 2021 | 2.92 B undefined | -671.08 M undefined | -822.17 M undefined |
| 2020 | 1.61 B undefined | -606.3 M undefined | 45.4 M undefined |
| 2019 | 991 M undefined | -287.1 M undefined | -403.9 M undefined |
| 2018 | 2.04 B undefined | 101 M undefined | 2.18 B undefined |
| 2017 | 4.06 B undefined | 281.3 M undefined | 194.5 M undefined |
| 2016 | 3.93 B undefined | 297.9 M undefined | 201.6 M undefined |
| 2015 | 3.9 B undefined | 300.6 M undefined | 241 M undefined |
| 2014 | 3.88 B undefined | 348.9 M undefined | 350.3 M undefined |
| 2013 | 3.57 B undefined | 242.2 M undefined | 121.5 M undefined |
| 2012 | 3.4 B undefined | 206 M undefined | 111 M undefined |
| 2011 | 3.38 B undefined | 225.8 M undefined | 127.3 M undefined |
| 2010 | 2.53 B undefined | 180.4 M undefined | 152.2 M undefined |
| 2009 | 2.32 B undefined | 146.7 M undefined | 76.8 M undefined |
| 2008 | 2.04 B undefined | 124.6 M undefined | 59.2 M undefined |
| 2007 | 1.77 B undefined | 118 M undefined | 79.2 M undefined |
| 2006 | 1.72 B undefined | 112.3 M undefined | 44.1 M undefined |
| 2005 | 1.63 B undefined | 91.5 M undefined | 38.3 M undefined |
| 2004 | 1.51 B undefined | 75.6 M undefined | 30 M undefined |
| Revenue | EBIT | Net Income | |
|---|---|---|---|
| 2004 | 1.51 B CNY | 75.6 M CNY | 30 M CNY |
| 2005 | 1.63 B CNY | 91.5 M CNY | 38.3 M CNY |
| 2006 | 1.72 B CNY | 112.3 M CNY | 44.1 M CNY |
| 2007 | 1.77 B CNY | 118 M CNY | 79.2 M CNY |
| 2008 | 2.04 B CNY | 124.6 M CNY | 59.2 M CNY |
| 2009 | 2.32 B CNY | 146.7 M CNY | 76.8 M CNY |
| 2010 | 2.53 B CNY | 180.4 M CNY | 152.2 M CNY |
| 2011 | 3.38 B CNY | 225.8 M CNY | 127.3 M CNY |
| 2012 | 3.4 B CNY | 206 M CNY | 111 M CNY |
| 2013 | 3.57 B CNY | 242.2 M CNY | 121.5 M CNY |
| 2014 | 3.88 B CNY | 348.9 M CNY | 350.3 M CNY |
| 2015 | 3.9 B CNY | 300.6 M CNY | 241 M CNY |
| 2016 | 3.93 B CNY | 297.9 M CNY | 201.6 M CNY |
| 2017 | 4.06 B CNY | 281.3 M CNY | 194.5 M CNY |
| 2018 | 2.04 B CNY | 101 M CNY | 2.18 B CNY |
| 2019 | 991 M CNY | -287.1 M CNY | -403.9 M CNY |
| 2020 | 1.61 B CNY | -606.3 M CNY | 45.4 M CNY |
| 2021 | 2.92 B CNY | -671.08 M CNY | -822.17 M CNY |
| 2022 | 2.71 B CNY | -893.77 M CNY | -1.18 B CNY |
| 2023 | 4.62 B CNY | -329.54 M CNY | -368.36 M CNY |
| 2024e | 5.6 B CNY | 178.77 M CNY | 91.32 M CNY |
| 2025e | 6.75 B CNY | 376.73 M CNY | 308.2 M CNY |
| 2026e | 7.96 B CNY | 816.08 M CNY | 438.33 M CNY |
XiAn International Medical Investment Co stock margins CNE000000016 ·
The XiAn International Medical Investment Co margin analysis displays the gross margin, EBIT margin, as well as the profit margin of XiAn International Medical Investment Co. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for XiAn International Medical Investment Co.
3 years
5 years
10 years
25 Years
Max
Gross margin
EBIT margin
Profit margin
Details
Margin
ⓘUnderstanding Gross Margin
The gross margin, expressed as a percentage, delineates the gross profit made from the XiAn International Medical Investment Co's sales revenue. A higher gross margin percentage indicates that the XiAn International Medical Investment Co retains more revenue after accounting for the costs of goods sold. Investors use this metric to gauge financial health and operational efficiency, as well as to compare it with competitors and industry averages.
EBIT Margin Analysis
EBIT margin represents the XiAn International Medical Investment Co's earnings before interest and taxes. Analyzing the EBIT margin over different years provides insights into the operational profitability and efficiency, excluding the effects of financial leverage and tax structure. A growing EBIT margin over the years signifies improving operational performance.
Revenue Margin Insights
The revenue margin demonstrates the XiAn International Medical Investment Co's total revenue generated. When comparing the revenue margin year over year, investors can gauge the XiAn International Medical Investment Co's growth and market expansion. It is essential to compare the revenue margin with the gross and EBIT margins to understand the cost and profit structures better.
Interpreting Expectations
The expected values for gross, EBIT, and revenue margins provide future financial outlook of the XiAn International Medical Investment Co. Investors should compare these expectations with historical data to understand potential growth and risk factors. It is crucial to consider the underlying assumptions and methodologies used in projecting these expected values to make informed investment decisions.
Comparative Analysis
Comparing the gross, EBIT, and revenue margins, both yearly and over multiple years, enables investors to perform a comprehensive analysis of the XiAn International Medical Investment Co's financial health and growth prospects. Evaluating the trends and patterns in these margins helps in identifying strengths, weaknesses, and potential investment opportunities.
XiAn International Medical Investment Co Margin History
| XiAn International Medical Investment Co Gross margin | XiAn International Medical Investment Co Profit margin | XiAn International Medical Investment Co EBIT margin | XiAn International Medical Investment Co Profit margin |
|---|---|---|---|
| 2026e | 9.52 % | 10.25 % | 5.5 % |
| 2025e | 9.52 % | 5.58 % | 4.57 % |
| 2024e | 9.52 % | 3.19 % | 1.63 % |
| 2023 | 9.52 % | -7.14 % | -7.98 % |
| 2022 | -6.75 % | -32.97 % | -43.4 % |
| 2021 | 1.47 % | -22.97 % | -28.15 % |
| 2020 | -9.21 % | -37.73 % | 2.83 % |
| 2019 | 14.31 % | -28.97 % | -40.76 % |
| 2018 | 21.6 % | 4.95 % | 107.11 % |
| 2017 | 19.26 % | 6.93 % | 4.79 % |
| 2016 | 19.57 % | 7.58 % | 5.13 % |
| 2015 | 19.41 % | 7.71 % | 6.18 % |
| 2014 | 19.79 % | 8.98 % | 9.02 % |
| 2013 | 19.07 % | 6.79 % | 3.41 % |
| 2012 | 18.3 % | 6.05 % | 3.26 % |
| 2011 | 16.22 % | 6.68 % | 3.77 % |
| 2010 | 17.64 % | 7.14 % | 6.02 % |
| 2009 | 14.49 % | 6.33 % | 3.31 % |
| 2008 | 15.14 % | 6.1 % | 2.9 % |
| 2007 | 15.89 % | 6.66 % | 4.47 % |
| 2006 | 15.16 % | 6.52 % | 2.56 % |
| 2005 | 11.34 % | 5.62 % | 2.35 % |
| 2004 | 11.54 % | 5.01 % | 1.99 % |
| Gross margin | EBIT margin | Profit margin | |
|---|---|---|---|
| 2004 | 11.54 % | 5.01 % | 1.99 % |
| 2005 | 11.34 % | 5.62 % | 2.35 % |
| 2006 | 15.16 % | 6.52 % | 2.56 % |
| 2007 | 15.89 % | 6.66 % | 4.47 % |
| 2008 | 15.14 % | 6.1 % | 2.9 % |
| 2009 | 14.49 % | 6.33 % | 3.31 % |
| 2010 | 17.64 % | 7.14 % | 6.02 % |
| 2011 | 16.22 % | 6.68 % | 3.77 % |
| 2012 | 18.3 % | 6.05 % | 3.26 % |
| 2013 | 19.07 % | 6.79 % | 3.41 % |
| 2014 | 19.79 % | 8.98 % | 9.02 % |
| 2015 | 19.41 % | 7.71 % | 6.18 % |
| 2016 | 19.57 % | 7.58 % | 5.13 % |
| 2017 | 19.26 % | 6.93 % | 4.79 % |
| 2018 | 21.6 % | 4.95 % | 107.11 % |
| 2019 | 14.31 % | -28.97 % | -40.76 % |
| 2020 | -9.21 % | -37.73 % | 2.83 % |
| 2021 | 1.47 % | -22.97 % | -28.15 % |
| 2022 | -6.75 % | -32.97 % | -43.4 % |
| 2023 | 9.52 % | -7.14 % | -7.98 % |
| 2024e | 9.52 % | 3.19 % | 1.63 % |
| 2025e | 9.52 % | 5.58 % | 4.57 % |
| 2026e | 9.52 % | 10.25 % | 5.5 % |
XiAn International Medical Investment Co Aktienanalyse
What does XiAn International Medical Investment Co do?
XiAn International Medical Investment Co ist eines der beliebtesten Unternehmen auf Eulerpool.com.Revenue Details
Understanding XiAn International Medical Investment Co's Sales Figures
The sales figures of XiAn International Medical Investment Co originate from the total revenue accrued from goods sold or services provided during a specific time period. These numbers are a direct reflection of the company’s ability to translate its products or services into revenue, indicating the demand and market presence.
Year-to-Year Comparison
Analyzing XiAn International Medical Investment Co’s yearly sales data offers insights into the company’s growth and stability. An increase in sales suggests a growing demand for its offerings, efficient marketing, or expansion into new markets. Conversely, a decline might indicate market saturation, increased competition, or less effective strategies.
Impact on Investments
Investors often scrutinize XiAn International Medical Investment Co's sales data to evaluate its financial health and growth prospects. Consistent sales growth can be a promising indicator of the company’s profitability and potential return on investment, influencing stock prices and investor confidence.
Interpreting Sales Fluctuations
Increases in XiAn International Medical Investment Co’s sales indicate market growth, innovation, or effective marketing, often leading to a surge in stock prices. A decline, however, can signal challenges requiring strategic adjustments to enhance market share and profitability.
Frequently Asked Questions about XiAn International Medical Investment Co stock
How much was the turnover of the company XiAn International Medical Investment Co compared to the previous year?
The revenue of XiAn International Medical Investment Co has increased by 21.22% increased compared to the previous year.
What does revenue mean for investors?
The revenue of a company is an important indicator of its financial performance and attractiveness for investors.
Which factors influence the revenue of XiAn International Medical Investment Co?
The revenue of XiAn International Medical Investment Co is influenced by various factors, including the demand for its products and services, market conditions, and prices.
How is the revenue of XiAn International Medical Investment Co measured?
Revenue is typically measured in units referring to the sale of goods and services provided by the company.
How does an increase in sales affect investments?
An increase in revenue can prompt investors to invest more money in the company as it serves as a positive signal for its financial performance and growth prospects.
What are the possible risks associated with a declining revenue?
A decline in revenue can prompt investors to invest less money in the company, as it is a negative signal for its financial performance and growth prospects.
Why is the sales revenue of XiAn International Medical Investment Co so important for investors?
The revenue of XiAn International Medical Investment Co is an important indicator of financial performance and attractiveness for investors.
What strategic measures can a company take to increase revenue?
A company can take various strategic measures to increase revenue, including developing new products and services, introducing new pricing models, and expanding into new markets.
How much dividend does XiAn International Medical Investment Co pay?
Over the past 12 months, XiAn International Medical Investment Co paid a dividend of 0.09 CNY . This corresponds to a dividend yield of about 1.47 %. For the coming 12 months, XiAn International Medical Investment Co is expected to pay a dividend of 0.03 CNY.
What is the dividend yield of XiAn International Medical Investment Co?
The current dividend yield of XiAn International Medical Investment Co is 1.47 %.
When does XiAn International Medical Investment Co pay dividends?
XiAn International Medical Investment Co pays a quarterly dividend. This is distributed in the months of July, June, August, July.
How secure is the dividend of XiAn International Medical Investment Co?
XiAn International Medical Investment Co paid dividends every year for the past 3 years.
What is the dividend of XiAn International Medical Investment Co?
For the upcoming 12 months, dividends amounting to 0.03 CNY are expected. This corresponds to a dividend yield of 0.57 %.
In which sector is XiAn International Medical Investment Co located?
XiAn International Medical Investment Co is assigned to the 'Health' sector.
Wann musste ich die Aktien von XiAn International Medical Investment Co kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of XiAn International Medical Investment Co from 6/28/2019 amounting to 0.087 CNY, you needed to have the stock in your portfolio before the ex-date on 6/28/2019.
When did XiAn International Medical Investment Co pay the last dividend?
The last dividend was paid out on 6/28/2019.
What was the dividend of XiAn International Medical Investment Co in the year 2023?
In the year 2023, XiAn International Medical Investment Co distributed 0 CNY as dividends.
In which currency does XiAn International Medical Investment Co pay out the dividend?
The dividends of XiAn International Medical Investment Co are distributed in CNY.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
Andere Kennzahlen von XiAn International Medical Investment Co
Our stock analysis for XiAn International Medical Investment Co Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of XiAn International Medical Investment Co Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.
- XiAn International Medical Investment Co Revenue
- XiAn International Medical Investment Co Net Income
- XiAn International Medical Investment Co P/E
- XiAn International Medical Investment Co P/S
- XiAn International Medical Investment Co EBIT
- XiAn International Medical Investment Co Dividend
- XiAn International Medical Investment Co Stocks
- XiAn International Medical Investment Co Market capitalization
- XiAn International Medical Investment Co Debt
- XiAn International Medical Investment Co Liabilities
- XiAn International Medical Investment Co Equity
- XiAn International Medical Investment Co AAQS
- XiAn International Medical Investment Co Employees
- XiAn International Medical Investment Co ROE
- XiAn International Medical Investment Co ROA
- XiAn International Medical Investment Co ROCE